NO941073D0 - Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater - Google Patents

Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater

Info

Publication number
NO941073D0
NO941073D0 NO941073A NO941073A NO941073D0 NO 941073 D0 NO941073 D0 NO 941073D0 NO 941073 A NO941073 A NO 941073A NO 941073 A NO941073 A NO 941073A NO 941073 D0 NO941073 D0 NO 941073D0
Authority
NO
Norway
Prior art keywords
phenylglycinamide
acid derivatives
phenylacetic acid
heterocyclic substituted
substituted phenylacetic
Prior art date
Application number
NO941073A
Other languages
English (en)
Other versions
NO941073L (no
Inventor
Ulrich E Mueller
Juergen Dressel
Peter Fey
Rudolf Hanko
Walter Huebsch
Thomas Kraemer
Matthias Mueller-Gliemann
Martin Beuck
Stanislav Kazda
Stefan Wohlfeil
Andreas Knorr
Johannes-Peter Stasch
Siegfried Zaiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO941073D0 publication Critical patent/NO941073D0/no
Publication of NO941073L publication Critical patent/NO941073L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO941073A 1993-03-26 1994-03-24 Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater NO941073L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4309968A DE4309968A1 (de) 1993-03-26 1993-03-26 Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten

Publications (2)

Publication Number Publication Date
NO941073D0 true NO941073D0 (no) 1994-03-24
NO941073L NO941073L (no) 1994-09-27

Family

ID=6484001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941073A NO941073L (no) 1993-03-26 1994-03-24 Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater

Country Status (15)

Country Link
EP (1) EP0622358A1 (no)
JP (1) JPH06329637A (no)
KR (1) KR940021532A (no)
CN (1) CN1102645A (no)
AU (1) AU5788694A (no)
CA (1) CA2119669A1 (no)
CZ (1) CZ71094A3 (no)
DE (1) DE4309968A1 (no)
FI (1) FI941380A (no)
HU (1) HUT68514A (no)
IL (1) IL109093A0 (no)
NO (1) NO941073L (no)
NZ (1) NZ260163A (no)
SK (1) SK35094A3 (no)
ZA (1) ZA942119B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996036591A1 (fr) * 1995-05-19 1996-11-21 Kissei Pharmaceutical Co., Ltd. Derives de 2-hydroxyphenylalkylamine et inhibiteurs de la reaction de maillard
DE19613550A1 (de) * 1996-04-04 1997-10-09 Bayer Ag Neue Pyrimido[1,2-a]indole
EP0802192A1 (de) * 1996-04-17 1997-10-22 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung
DE19619950A1 (de) 1996-04-17 1997-10-23 Bayer Ag Heterocyclisch-substituierte Phenylglycinolamide
DE19615265A1 (de) * 1996-04-18 1997-12-04 Bayer Ag Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
EP1013273A1 (en) * 1998-12-23 2000-06-28 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
TR200805741T2 (tr) * 1998-12-23 2008-10-21 Novartis Ag At-1 veya at-2 reseptörlerindeki artışın neden olduğu hastalıkların tedavisi için at-1 reseptör antagonisti veya at-2 reseptör modülatörünün kullanımı@

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide

Also Published As

Publication number Publication date
EP0622358A1 (de) 1994-11-02
DE4309968A1 (de) 1994-09-29
NO941073L (no) 1994-09-27
ZA942119B (en) 1994-11-07
FI941380A0 (fi) 1994-03-24
CZ71094A3 (en) 1994-10-19
AU5788694A (en) 1994-09-29
IL109093A0 (en) 1994-06-24
HUT68514A (en) 1995-06-28
JPH06329637A (ja) 1994-11-29
FI941380A (fi) 1994-09-27
NZ260163A (en) 1996-02-27
HU9400865D0 (en) 1994-06-28
KR940021532A (ko) 1994-10-19
SK35094A3 (en) 1995-10-11
CA2119669A1 (en) 1994-09-27
CN1102645A (zh) 1995-05-17

Similar Documents

Publication Publication Date Title
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
NO983940D0 (no) Derivater av substituert 4-hydroksy-fenylalcanosyre med agostisk aktivitet for ppargamma
FI944800A (fi) Indoli-2-karboksyylihappojohdannaisia
DE69703385T2 (de) Alkoxyessigsäure-derivate
ATE257836T1 (de) Salz von naphthyridincarbonsäure-derivaten
EE9500059A (et) Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena
AU3150289A (en) Heterocyclic substituted dihaloisonicotinic acid amide derivatives
FI955164A0 (fi) Heterosykliset johdannaiset
NO923580L (no) Substituerte imidazolylpropensyrederivater
FI970110A (fi) Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia
NO941336D0 (no) Heterocykliske iminobismetylen-bisfosfonsyrederivater
ATE230734T1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
NO941073D0 (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
EE9700186A (et) Klavulaanhappe soolad
FI941149A0 (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
DK0946548T3 (da) Nye heterocykliske substituerede pyrrolidinamidderivater
DE59606437D1 (de) 5-pyrazolylbenzosäure-derivate als herbizide
DE69502982T2 (de) Herstellung geschützter Aminothiazolylessigsäurederivate
NO20002154D0 (no) Nye heterocykliske substituerte alfa-hydroksykarboksylsyre- derivater
NO995841L (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2- fenylpropionsyre-derivater
FI940133A (fi) Uudet nikotiinihappojohdannaiset
NO940131D0 (no) Salter av 4-pyrimidinon-derivater for framasoeytisk anvendelse
NO991098D0 (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
DE633242T1 (de) Derivate der Heptansäure.